Security key
53630X203
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)
CUSIP: 53630X203
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 8,072,317
- Total 13F shares
- 486,671
- Share change
- -57,853
- Total reported value
- $2,375,002
- Price per share
- $4.88
- Number of holders
- 17
- Value change
- -$289,398
- Number of buys
- 5
- Number of sells
- 6
Report period
Q4 2024
Institutions
17
Top holders
10
LPCN full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Lipocine Inc. SEC filings
Lipocine Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53630X203
Recent filing periods:
Top shareholders of LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
221,459
|
$994,351 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
89,272
|
$400,831 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.74%
|
59,413
|
$266,764 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
54,216
|
$243,467 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.5%
|
40,332
|
$181,091 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
25,008
|
$112,286 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.23%
|
18,626
|
$83,631 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.22%
|
18,016
|
$80,892 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
13,160
|
$59,088 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
2,634
|
$11,827 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,066
|
$4,786 | — | 30 Sep 2024 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0.01%
|
471
|
$2,115 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
423
|
$1,899 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
227
|
$1,018 | — | 30 Sep 2024 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0%
|
74
|
$333 | — | 30 Sep 2024 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
59
|
$265 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
56
|
$252 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
12
|
$54 | — | 30 Sep 2024 | |
| Morgan R. Brown |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
176,000
|
$46,746 | — | 07 Dec 2021 | |
| George Nomikos |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
125,000
|
$33,200 | — | 01 Nov 2022 |
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q4 2024
As of 31 Dec 2024,
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
486,671 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, MORGAN STANLEY, and Tower Research Capital LLC (TRC).
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
18
Q4 2024 holders
17
Holder diff
-1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.